A Clinical Evaluation of Circulating MiR-106a and Raf-1 as Breast Cancer Diagnostic and Prognostic Markers.

Elham Ahmed Mohmmed Wafaa Ghoneim ShoushaAbeer Salah El-SaiidShimaa Shawki Ramadan

Published in: Asian Pacific journal of cancer prevention : APJCP (2021)

Expression of MiR-106a gene can be used as a diagnostic and prognostic noninvasive biomarker which can stimulates breast cancer cell invasion and proliferation through downregulation of Raf-1 levels.<br />.

Keyphrases

cell proliferation
clinical evaluation
long non coding rna
poor prognosis
long noncoding rna
signaling pathway
genome wide
gene expression
binding protein
young adults
breast cancer risk
childhood cancer